INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

18,675 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
VC
Voss Capital, LP10% Owner
FLYWFlywire Corp
Open-market sale
SELL$146K
7,763 sh
Aug 28, 2026Sep 1, 2026
Page 129 of 467
← PrevNext →

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUY
traded Aug 28, 2026
+4d
SEC Form 4

Evidence

16
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$2.36M
80.7K sh
Aug 28, 2026Sep 1, 2026
traded Aug 28, 2026
+4dSEC Form 4

Evidence

16
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$3.94M
130.8K sh
Aug 28, 2026Sep 1, 2026
traded Aug 28, 2026
+4dSEC Form 4

Evidence

16
RB
Ragsdale BruceChief Operating Officer
ICHRICHOR HOLDINGS, LTD.
Open-market sale · 10b5-1 plan
SELL$334K
6,456 sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC Form 4

Evidence

14
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale
SELL$1,825
10 sh
Aug 28, 2026Sep 1, 2026
traded Aug 28, 2026
+4dSEC Form 4

Evidence

14
BM
Bonnell Brian MichaelChief Financial Officer
ICUIICU MEDICAL INC/DE
Open-market sale · 10b5-1 plan
SELL$1.12M
6,381 sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC Form 4

Evidence

12
RM
Rapp Karen MarieDirector
PLXSPLEXUS CORP
Open-market sale · 10b5-1 plan
SELL$120K
500 sh
Aug 31, 2026Sep 1, 2026
traded Aug 31, 2026
+1dSEC Form 4

Evidence

9
RB
Ragsdale BruceChief Operating Officer
ICHRICHOR HOLDINGS, LTD.
Open-market sale · 10b5-1 plan
SELL$205K
3,931 sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC Form 4

Evidence

9
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$127K
15.0K sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC Form 4

Evidence

8
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$318K
4,568 sh
Aug 28, 2026Sep 1, 2026
traded Aug 28, 2026
+4dSEC Form 4

Evidence

7
PP
Pisano PauloCHIEF HUMAN RESOURCES OFFICER
BKNGBooking Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$610K
3,000 sh
Aug 31, 2026Sep 1, 2026
traded Aug 31, 2026
+1dSEC Form 4

Evidence

6
RB
Ragsdale BruceChief Operating Officer
ICHRICHOR HOLDINGS, LTD.
Open-market sale · 10b5-1 plan
SELL$11K
200 sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC Form 4

Evidence

6
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
5,000 sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC Form 4

Evidence

6
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$245K
1,200 sh
Aug 31, 2026Sep 1, 2026
traded Aug 31, 2026
+1dSEC Form 4

Evidence

3
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$3,089
100 sh
Aug 28, 2026Sep 1, 2026
traded Aug 28, 2026
+4dSEC Form 4

Evidence

3
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
679 sh
Aug 28, 2026Sep 1, 2026
traded Aug 28, 2026
+4dSEC Form 4

Evidence

1
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
1,452 sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC Form 4

Evidence

50
LB
Laughton Mary BethDirector
CARTMaplebear Inc.
Open-market sale
SELL$515K
10.2K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

48
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale
SELL$18.20M
600.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

44
CR
Courtney Mark RVice President of Supply Chain
KTCCKEY TRONIC CORP
Open-market sale
SELL$3,297
884 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

44
AL
Agress Adam LEVP Business Development
KTCCKEY TRONIC CORP
Open-market sale
SELL$6,654
1,784 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

41
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale
SELL$4.62M
150.0K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC Form 4

Evidence

40
KH
Knaggs David H.EVP of Quality and IS
KTCCKEY TRONIC CORP
Open-market sale
SELL$5,528
1,482 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

40
OT
Orebaugh Chad ThomasEVP of Engineering
KTCCKEY TRONIC CORP
Open-market sale
SELL$5,528
1,482 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

40
VG
Voorhees Anthony GeneEVP-Admin, CFO, Treasurer
KTCCKEY TRONIC CORP
Open-market sale
SELL$8,400
2,252 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

38
CE
Chamberlain Paul EdwardDirector
TNETTRINET GROUP, INC.
Open-market sale
SELL$167K
2,400 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

36
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Open-market sale
SELL$146K
12.0K sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC Form 4

Evidence

34
ES
Eddy ShalevDirector
ETOReToro Group Ltd.
Open-market sale
SELL$3.09M
99.1K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC Form 4

Evidence

33
RB
Robinson Kenneth B.Director
PCTYPaylocity Holding Corp
Open-market sale
SELL$127K
800 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

33
HN
Hathi NeeshaMD, Head Wealth Adv, Bnk, Tst
SCHWSCHWAB CHARLES CORP
Open-market sale · 10b5-1 plan
SELL$343K
3,177 sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC Form 4

Evidence

32
SM
Sever MichalCMO
NYAXNayax Ltd.
Open-market sale
SELL$2,013
38 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

31
JO
Jones Donnie O.SVP- Utility Operations (OG&E)
OGEOGE ENERGY CORP.
Open-market sale
SELL$300K
6,508 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

31
CE
Chamberlain Paul EdwardDirector
NOWServiceNow, Inc.
Open-market sale
SELL$366K
2,700 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

28
MG
Malka GabrielChief Operating Officer
RDWRRADWARE LTD
Open-market sale
SELL$195K
6,500 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

28
VC
VandenAkker ColeChief Sales Officer
COOKTraeger, Inc.
Open-market sale
SELL$152K
2,750 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

27
MC
McGogney ConnorChief Financial Officer
CRTOCriteo S.A.
Open-market sale
SELL$4,458
258 sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC Form 4

Evidence

27
KM
Komasinski MichaelDirector, CEO
CRTOCriteo S.A.
Open-market sale
SELL$29K
1,656 sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC Form 4

Evidence

27
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$4.92M
19.6K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC Form 4

Evidence

27
DR
Damon RyanChief Legal Officer
CRTOCriteo S.A.
Open-market sale
SELL$14K
789 sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC Form 4

Evidence

26
PJ
Polak Aldo J.Director
EVTCEVERTEC, Inc.
Open-market sale
SELL$30K
1,000 sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC Form 4

Evidence

UPBDUPBOUND GROUP, INC.Nov 2 – Nov 3
7 insiders$1.34M
  • SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  • BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  • SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K